艾昆纬-美国在生物制药领域的卓越（英）

MAY2 0 2 5America’s Greatness in the Biopharmaceutical SectorPERSPECTIVESustaining U.S. LeadershipAmerica’s Greatness in the Biopharmaceutical Sector: Sustaining U.S. Leadership©2025 IQVIA and its affiliates. All reproduction rights, quotations, broadcasting, publications reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without express written consent of IQVIA and the IQVIA Institute.IntroductionThe U.S. biopharmaceuticals sector — the collection of companies that discover, develop, and commercialize therapeutics and medicines for patients in the U.S. and around the world — contributes to the U.S. economy, healthcare system, and society through its focus on innovation and technology, while concurrently reducing mortality and morbidity from illness. The sector has developed an eco-system that combines a multitude of scientific discovery platforms with robust dissemination of information, intellectual property protection, a global talent pool, funding markets that provide liquidity, and a relatively transparent and responsive regulatory regime. This eco-system has delivered enormous value and has been a major net contributor to the U.S.; however, there are aspects of the current system that can be improved, and competition from other parts of the world is increasing. Addressing these issues — while maintaining or increasing the strengths of the existing eco-system — can contribute to the broader goals of enhancing America’s global leadership and at the same time increase the contribution of this critical strategic sector. This Perspective from the IQVIA Institute for Human Data Science is intended to contribute to the current discussion around several Executive Orders and policy proposals being discussed or implemented by the current U.S. Administration. It draws on recent research by the IQVIA Institute and others to bring a balanced and objective view of how the goals of the administration can be best supported by a vital and sustained biopharmaceutical sector. This Perspective is produced as a public service without external funding or support.Find Out MoreIf you wish to receive future reports from the IQVIA Institute for Human Data Science or join our mailing list, visit iqviainstitute.org. MURRAY AITKENExecutive Director IQVIA Institute for Human Data ScienceREFERENCING THIS REPORTPlease use this format when referencing content from this report:Source: IQVIA Institute for Human Data Science. America’s Greatness in the Biopharmaceutical Sector: Sustaining U.S. Leadership. May 2025. Available from www.iqviainstitute.orgiqviainstitute.org | 1American companies have led the world in biomedical discovery and clinical research, and bring substantial direct and indirect economic contributions to the U.S.Biopharmaceuticals are a strategic sector for the U.S. The U.S. biopharmaceutical sector